Condition
Postprandial Glucose Regulation
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06906965Not ApplicableCompletedPrimary
Effect of the Imera Cultivar Carob in Postprandial Glycemia
NCT05139355Not ApplicableCompletedPrimary
Health Effects of Oat and Oat Polar Lipids in Human
NCT04542265Not ApplicableCompletedPrimary
Health Effects of Oat and Oat Bioactive in Human
NCT03830736Not ApplicableCompletedPrimary
Health Effects of Oats and Oat Bioactive in Human
Showing all 4 trials